Wilmington Pharmaceuticals

About:

Wilmington Pharmaceuticals develops and licenses formulations for drug developments.

Website: http://www.wilmingtonpharma.com

Top Investors: Wilmington Investor Network, Emergent Growth Fund

Description:

At Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.

Total Funding Amount:

$1.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wilmington, North Carolina, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)wilmingtonpharma.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2006-10-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai